Q32 Bio (QTTB) Debt to Equity (2023 - 2026)

Q32 Bio's Debt to Equity history runs 4 years deep, the most recent figure standing at $0.18 for Q1 2026.

• In Q1 2026, Debt to Equity rose 105.58% year-over-year to $0.18; the TTM figure through Mar 2026 stood at $0.18 (up 105.58% YoY), while the FY2025 annual figure was $0.23, down 89.64% from the prior year.
• Debt to Equity was $0.18 for Q1 2026 at Q32 Bio, down from $0.23 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $2.23 in Q4 2024 to a low of -$3.16 in Q1 2025.
• Historically, Debt to Equity has averaged -$0.09 across 4 years, with a median of $0.2 in 2025.
• The sharpest annual moves came in 2024 and 2025: Debt to Equity soared 7570.99% in 2024, then tumbled 1335.7% in 2025.
• A 4-year view of Debt to Equity shows it stood at -$0.03 in 2023, then jumped by 7570.99% to $2.23 in 2024, then plunged by 89.64% to $0.23 in 2025, then declined by 23.58% to $0.18 in 2026.
• The last three Debt to Equity figures came in at $0.18 (Q1 2026), $0.23 (Q4 2025), and -$0.61 (Q3 2025), per Business Quant data.